IP Verse

A Marine Oil Formulation Comprising Reservatrol Or Derivatives Thereof For Use In Treating, Delaying And/Or Preventing Alzheimer'S Desease - EP3016666

The patent EP3016666 was granted to Smartfish on May 15, 2019. The application was originally filed on Jun 13, 2014 under application number EP14811285A. The patent is currently recorded with a legal status of "Revoked".

EP3016666

SMARTFISH
Application Number
EP14811285A
Filing Date
Jun 13, 2014
Status
Revoked
Sep 2, 2022
Publication Date
May 15, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NUTRICIAFeb 13, 2020NEDERLANDSCH OCTROOIBUREAU -

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTDE202007013532U
INTERNATIONAL-SEARCH-REPORTEP2218342
INTERNATIONAL-SEARCH-REPORTUS2002182196
INTERNATIONAL-SEARCH-REPORTUS2006172012
INTERNATIONAL-SEARCH-REPORTUS2008058418
INTERNATIONAL-SEARCH-REPORTWO0147377
INTERNATIONAL-SEARCH-REPORTWO2007001185
INTERNATIONAL-SEARCH-REPORTWO2007064222
INTERNATIONAL-SEARCH-REPORTWO2009120091
INTERNATIONAL-SEARCH-REPORTWO2012025229
INTERNATIONAL-SEARCH-REPORTWO2012128982
OPPOSITIONUS2006172012
OPPOSITIONUS6184248
OPPOSITIONWO2004105517
OPPOSITIONWO2007064222
OPPOSITIONWO2009120091
OPPOSITIONWO2014000356
SEARCHEP2279667
SEARCHWO2011005113

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
INTERNATIONAL-SEARCH-REPORT- THOMAS, JENCY ET AL., "Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57B1/6 mice", JOURNAL OF NUTRITIONAL BIOCHEMISTRY, (20130101), vol. 24, no. 10, doi:10.1016/J.JNUTBIO.2013.03.002, pages 1735 - 1740, XP028731176
OPPOSITION- BROTHERS et al., "The physiological roles of amyloid-beta peptide hint at new ways to treat Alzheimer's Disease", Frontiers in aging Neuroscience, (20180000), vol. 10, page 118, XP055687105
OPPOSITION- MORAN C et al., "Effects of a six-month multi-ingredient nutrition supplement intervention of omega-3 polyunsaturated fatty acids, vitamin D, resveratrol, and whey protein on cognitive function in older adults: a randomised, double-blind, controlled trial", J Prev Alz Dis, (20180000), vol. 5, no. 3, pages 175 - 183, XP055687109
OPPOSITION- Shrikanta Akshatha; Kumar Anbarasu; Govindaswamy Vijayalakshmi, "Resveratrol content and antioxidant properties of underutilized fruits", Journal of Food Science and Technology, Springer (India) Private Ltd., India, India, (20130504), vol. 52, no. 1, doi:10.1007/s13197-013-0993-z, ISSN 0022-1155, pages 383 - 390, XP035422023
OPPOSITION- Singh Jatinder Pal; Kaur Amritpal; Shevkani Khetan; Singh Narpinder, "Composition, bioactive compounds and antioxidant activity of common Indian fruits and vegetables", Journal of Food Science and Technology, Springer (India) Private Ltd., India, India, (20161125), vol. 53, no. 11, doi:10.1007/s13197-016-2412-8, ISSN 0022-1155, pages 4056 - 4066, XP036116635
OPPOSITION- KARUPPAGOUNDER S et al., "Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's Disease", Neurochem Int, (20090200), vol. 54, no. 2, pages 11 - 118, XP002524171
OPPOSITION- GLUHM S et al., "Cognitive performance on the Mini-Mental State Examination and the Montreal Cognitive Assessment across the healthy adult lifespan", Cogn. Behav. Neurol., (20130326), vol. 1, pages 1 - 5, XP055687108
OPPOSITION- REZAI-ZADEH et al., "Can peripheral leukocytes be used as Alzheimer's disease biomarkers?", Expert Neurother., (20091100), vol. 9, no. 11, doi:10.1586/ern.09.118, pages 1623 - 1633, XP055388638
OPPOSITION- KENNEDY D et al., "Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation", Am. J. Clin. Nutr, (20100000), vol. 91, pages 1590 - 7, XP055687113
SEARCH- KARUPPAGOUNDER S S ET AL, "Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease", NEUROCHEMISTRY INTERNATIONAL, ELSEVIER, AMSTERDAM, NL, (20090201), vol. 54, no. 2, doi:10.1016/J.NEUINT.2008.10.008, ISSN 0197-0186, pages 111 - 118, XP002524171 [Y] 1-9 * page 116 *
SEARCH- M. FIALA ET AL, "-3 Supplementation increases amyloid- phagocytosis and resolvin D1 in patients with minor cognitive impairment", THE FASEB JOURNAL, US, (20150324), vol. 29, no. 7, doi:10.1096/fj.14-264218, ISSN 0892-6638, pages 2681 - 2689, XP055340202 [T] * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents